Login to Your Account

Biotech Heavyweights Challenge Patent Position Held By Columbia

By Brady Huggett

Monday, August 4, 2003
Genzyme Corp., Biogen Inc. and Abbott Bioresearch Center filed suit earlier this summer against Columbia University in the U.S. District Court of Massachusetts, claiming that a new patent issued to the university in September 2002 that centered on cotransformation technology was "invalid and unenforceable." (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription